Jeffrey Tosoian

February 3, 2025

Study shows urine test for prostate cancer could be used at home

The results are important because it could enable at-home testing and increased access to testing for patients undergoing telehealth care.

October 31, 2024

Jeffrey Tosoian named chair of EDRN Prostate/GU Cancer Collaborative

The EDRN works to discover, develop and validate biomarkers and imaging methods to detect early-stage cancers, assess risk for developing cancer, and translate these tools into clinical tests.

(iStock image)
April 18, 2024

New urine test has higher diagnostic accuracy for prostate cancer

Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the U.S.